Terms: = Head and neck cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Treatment
1880 results:
1. Changes in the diagnosis of thyroid tumours in the 5th edition of the WHO classification of endocrine neoplasms.
J D
Cesk Patol; 2024; 60(1):59-63. PubMed ID: 38697828
[TBL] [Abstract] [Full Text] [Related]
2. Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer.
Shin DS; Basak S; Veena MS; Comin-Anduix B; Bhattacharya A; Dong TS; Ko A; Han P; Jacobs J; Moatamed NA; Avila L; Pellegrini M; Wang M; Srivatsan ES
Cancer Med; 2024 May; 13(9):e7212. PubMed ID: 38686626
[TBL] [Abstract] [Full Text] [Related]
3. A CT-based integrated model for preoperative prediction of occult lymph node metastasis in early tongue cancer.
Han W; Wang Y; Li T; Dong Y; Dang Y; He L; Xu L; Zhou Y; Li Y; Wang X
PeerJ; 2024; 12():e17254. PubMed ID: 38685941
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic accuracy of clinical visual assessment using endoscopic images for nasal cavity mass lesions.
Kwon KW; Yu MS
Sci Prog; 2024; 107(2):368504241248004. PubMed ID: 38683182
[No Abstract] [Full Text] [Related]
5. Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for treatment Investigation.
Wils LJ; Buijze M; Stigter-van Walsum M; Brink A; van Kempen BE; Peferoen L; Brouns ER; de Visscher JGAM; van der Meij EH; Bloemena E; Poell JB; Brakenhoff RH
Cells; 2024 Apr; 13(8):. PubMed ID: 38667326
[TBL] [Abstract] [Full Text] [Related]
6. Identification of two distinct head and neck squamous cell carcinoma subtypes based on fatty acid metabolism-related signatures: Implications for immunotherapy and chemotherapy.
Zou J; Dai Y; Xu G; Kai Y; Lan L; Zhang J; Wang Y
Medicine (Baltimore); 2024 Apr; 103(16):e37824. PubMed ID: 38640298
[TBL] [Abstract] [Full Text] [Related]
7. [Phase Ⅱ clinical trial of PD-1 inhibitor combined with chemotherapy for locally advanced resectable oral squamous cell carcinoma].
Wang HL; Yue K; Wu YS; Duan YS; Jing C; Wang XD
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Apr; 59(4):335-342. PubMed ID: 38599641
[No Abstract] [Full Text] [Related]
8. Cost-Utility Analysis of Early Detection with Ultrasonography of Differentiated Thyroid cancer: A Retrospective Study on a Korean Population.
Baek HS; Ha J; Kim K; Bae JS; Kim JS; Kim S; Lim DJ; Kim CM
Endocrinol Metab (Seoul); 2024 Apr; 39(2):310-323. PubMed ID: 38590123
[TBL] [Abstract] [Full Text] [Related]
9. Prediction of malignant esophageal fistula in esophageal cancer using a radiomics-clinical nomogram.
Zhu C; Sun W; Chen C; Qiu Q; Wang S; Song Y; Ma X
Eur J Med Res; 2024 Apr; 29(1):217. PubMed ID: 38570887
[TBL] [Abstract] [Full Text] [Related]
10. Development and validation of a nomogram model for predicting distant metastasis of aged ≥50 patients with thyroid carcinoma: a SEER database analysis.
Yu JW; Pang R; Liu B; Zhang L; Kong LY
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2351-2362. PubMed ID: 38567598
[TBL] [Abstract] [Full Text] [Related]
11. WET-UNet: Wavelet integrated efficient transformer networks for nasopharyngeal carcinoma tumor segmentation.
Zeng Y; Li J; Zhao Z; Liang W; Zeng P; Shen S; Zhang K; Shen C
Sci Prog; 2024; 107(2):368504241232537. PubMed ID: 38567422
[TBL] [Abstract] [Full Text] [Related]
12. STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance.
Li T; Zhang W; Niu M; Wu Y; Deng X; Zhou J
Front Immunol; 2024; 15():1342647. PubMed ID: 38550593
[TBL] [Abstract] [Full Text] [Related]
13. Development and internal validation of a nomogram based on peripheral blood inflammatory markers for predicting prognosis in nasopharyngeal carcinoma.
Lai J; Lin P; Zhuang J; Xie Z; Zhou H; Yang D; Chen Z; Jiang D; Huang J
Cancer Med; 2024 Apr; 13(7):e7135. PubMed ID: 38549496
[TBL] [Abstract] [Full Text] [Related]
14. Deciphering a Prognostic Signature Based on Soluble Mediators Defines the Immune Landscape and Predicts Prognosis in HNSCC.
Chi H; Peng G; Song G; Zhang J; Xie X; Yang J; Xu J; Zhang J; Xu K; Wu Q; Yang G
Front Biosci (Landmark Ed); 2024 Mar; 29(3):130. PubMed ID: 38538268
[TBL] [Abstract] [Full Text] [Related]
15. Online tools to predict individualised survival for primary oesophageal cancer patients with and without pathological complete response after neoadjuvant therapy followed by oesophagectomy: development and external validation of two independent nomograms.
Cao Y; Huang B; Tang H; Dong D; Shen T; Chen X; Feng X; Zhang J; Shi L; Li C; Jiao H; Tan L; Zhang J; Li H; Zhang Y
BMJ Open Gastroenterol; 2024 Mar; 11(1):. PubMed ID: 38538088
[TBL] [Abstract] [Full Text] [Related]
16. M6A-mediated molecular patterns and tumor microenvironment infiltration characterization in nasopharyngeal carcinoma.
Wang Y; Peng L; Wang F
Cancer Biol Ther; 2024 Dec; 25(1):2333590. PubMed ID: 38532632
[TBL] [Abstract] [Full Text] [Related]
17. Effect of radiotherapy on head and neck cancer tissues in patients receiving radiotherapy: a bioinformatics analysis-based study.
Guan Z; Liu J; Zheng L
Sci Rep; 2024 Mar; 14(1):6304. PubMed ID: 38491080
[TBL] [Abstract] [Full Text] [Related]
18. Correlation between morphological parameters and dosimetric parameters of the heart and spinal cord in the intermediate- and advanced-stage esophageal cancer.
Zhao W; Lan L; Xu B; Chen D; Zeng Y; Guo F; Zhang H
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2015. PubMed ID: 38488482
[TBL] [Abstract] [Full Text] [Related]
19. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.
Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
[TBL] [Abstract] [Full Text] [Related]
20. Perioperative or neoadjuvant chemotherapy for locally advanced gastric or gastroesophageal junction cancer: from independent evidence in the West, the East, and Japan to global collaboration.
Nakayama I; Ohashi M; Nunobe S
Chin Clin Oncol; 2024 Feb; 13(1):8. PubMed ID: 38453658
[TBL] [Abstract] [Full Text] [Related]
[Next]
